Leeds General Infirmary, also known as the LGI, is a large teaching hospital based in the centre of Leeds, West Yorkshire, England, and is part of the Leeds Teaching Hospitals NHS Trust. Its previous name The General Infirmary at Leeds is still sometimes used.

There are 1,103 beds in Leeds General Infirmary.

During the past decade, Leeds General Infirmary conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 24 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 16 clinical trials were completed. i.e. 72.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Leeds General Infirmary" #1 sponsor was "University of Leeds" with 10 trials, followed by "University College, London" with 8 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 7 trials sponsored, "Boston Scientific Corporation" with 4 trials sponsored and "Ipsen" with 4 trials sponsored. Other sponsors include 101 different institutions and companies that sponsored additional 88 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Leeds General Infirmary" #1 collaborator was "National Institute for Health Research, United Kingdom" with 5 trials as a collaborator, "The Leeds Teaching Hospitals NHS Trust" with 5 trials as a collaborator, "Imperial College Healthcare NHS Trust" with 3 trials as a collaborator, "London School of Hygiene and Tropical Medicine" with 3 trials as a collaborator and "British Heart Foundation" with 2 trials as a collaborator. Other collaborators include 122 different institutions and companies that were collaborators in the rest 124 trials.

According to Clinical.Site data, the most researched conditions in "Leeds General Infirmary" are "Cystic Fibrosis" (7 trials), "Lymphoma" (7 trials), "Aortic Valve Stenosis" (5 trials), "Atrial Fibrillation" (5 trials) and "Aortic Stenosis" (4 trials). Many other conditions were trialed in "Leeds General Infirmary" in a lesser frequency.

Most popular intervention types in "Leeds General Infirmary" are "Drug" (62 trials), "Device" (37 trials), "Other" (23 trials), "Biological" (16 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "IVA" (7 trials), "laboratory biomarker analysis" (6 trials), "cyclophosphamide" (4 trials) and "prednisolone" (4 trials). Other intervention names were less common.

The vast majority of trials in "Leeds General Infirmary" are 134 trials for "All" genders, 4 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Leeds General Infirmary". 1 are not yet recruiting, 19 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 80 completed trials in Leeds General Infirmary, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Leeds General Infirmary, 12 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 28 trials that are defined as “Not Applicable".